Soligenix

Soligenix Long-term Debt

The Long-Term Debt of Soligenix (SNGX) as of Oct 18, 2026 is 1.01 M USD. In the previous year, Long-Term Debt was 9.86 M USD — a change of -89.74% (lower).

Long-term Debt

1.01 MUSD

YoY

-89.74%

Last updated:

Long-Term Debt of Soligenix is 2023 1.01 M USD. Long-Term Debt of Soligenix was 2022 9.86 M USD. It decreases by -89.74% lower compared to the previous year.

The Soligenix Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2014
0.00 USD
Jan 1, 2015
0.00 USD
Jan 1, 2016
0.00 USD
Jan 1, 2017
0.00 USD
Jan 1, 2019
6,149.00 USD
Jan 1, 2020
10.07 M USD
Jan 1, 2021
9.86 M USD
Jan 1, 2023
1.01 M USD
The Soligenix Long-term Debt history
YEARLong-term DebtYoY
1.01 MUSD-89.74%
9.86 MUSD-2.11%
10.07 MUSD+163,648.35%
6,149.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Soligenix Stock analysis

What does Soligenix do? Soligenix Inc, trading under the ticker SNGX, is a biotechnology company based in Princeton, New Jersey. The company has an IPO date of April 4, 1994, and currently employs 13 people. Soligenix operates in the health care sector, specifically within biotechnology. The company focuses on developing and commercializing treatments for rare diseases. Its business segments include Specialized BioTherapeutics and Public Health Solutions. Under Specialized BioTherapeutics, Soligenix is developing SGX301, a photodynamic therapy using topical synthetic hypericin activated by visible light for cutaneous T-cell lymphoma (CTCL). The Public Health Solutions segment encompasses development programs for RiVax, a ricin toxin vaccine candidate, and SGX943, a therapeutic candidate targeting antibiotic-resistant and emerging infectious diseases. The company also references CTCL as an innate defense regulator technology, though this appears to be a misstatement as CTCL is a disease, not a technology. Soligenix's website is https://www.soligenix.com/. Soligenix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Soligenix stock

Long-Term Debt of Soligenix is 1.01 M USD in 2023.

Long-Term Debt of Soligenix changed from 9.86 M USD to 1.01 M USD, representing a -89.74% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt Soligenix since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Soligenix historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Soligenix

All Key Metrics — Soligenix